Emany Sravan Kumar
CIK 0001897662
SVP, Chief Financial OfficerDirector
Filings
19
Latest May 6, 2026
Issuers covered
4
Showing
19 of 19
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 75% | +4.7% | +7.1% | +17.5% | -13.1% |
| 90 days | 4 | 75% | +18.6% | +25.7% | +50.2% | -27.0% |
| 180 days | 3 | 67% | +13.9% | +3.6% | +84.8% | -46.6% |
| 365 days | 3 | 33% | -35.9% | -46.4% | +22.6% | -84.0% |
Issuers
Companies where Emany Sravan Kumar has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| IRWD | Ironwood Pharmaceuticals Inc | 10 | Nov 20, 2024 |
| ASRT | Assertio Holdings, Inc. | 4 | May 6, 2026 |
| BEAM | Beam Therapeutics Inc. | 4 | Apr 2, 2026 |
| KYTX | Kyverna Therapeutics, Inc. | 1 | Feb 26, 2026 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|